Speciality: Hematology
Description:
A warm welcome to all the medical professionals in this session, "An Eagle's View - Evidence-based discussion on Iron Deficiency Anemia." This discussion will provide a high-level, evidence-based overview of Iron Deficiency Anemia (IDA), the most common nutritional deficiency worldwide. Despite its prevalence, IDA is often underdiagnosed and undertreated, leading to significant health consequences. This session will offer a fresh perspective on the latest clinical data, moving beyond traditional approaches to focus on effective and patient-centered management strategies.
The discussion will explore the evidence supporting different therapeutic options, including oral iron supplementation and intravenous iron infusions. We'll delve into the specific patient populations that benefit most from each approach, such as those with intolerance to oral supplements, pregnant women, or patients with chronic conditions. Recent research has highlighted the improved safety and efficacy of modern intravenous iron formulations, making them a more viable and often preferred option for rapid iron replenishment and symptom relief. We will also address the challenges in diagnosis, particularly when inflammatory markers are elevated.
Therefore, get an overall knowledge of the evidence-based best practices in the diagnosis and treatment of iron deficiency anemia. Listen to the webinar, absorb the shared knowledge, and follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.
2.
recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.
3.
FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.
4.
Durvalumab Wins FDA Approval in Limited-Stage SCLC
5.
Telehealth in the pandemic era resulted in fewer therapy interruptions.
1.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
2.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
3.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
4.
AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined
5.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation